Objective: Diabetes devices, including continuous glucose monitors (CGMs) and insulin pumps, may significantly affect environmental sustainability and long-term resilience.
Research Design And Methods: This observational study enrolled 49 adults with diabetes using CGMs, insulin pumps, or multiple daily injections (MDIs; three or more per day). Participants completed daily surveys detailing the types and amounts of diabetes-related waste discarded.
Results: Of the 49 participants, 11 used MDIs and 38 used insulin pumps. Most were female (63%), were White (80%), had a bachelor's degree (90%), lived in suburban/urban areas (86%), and were aged <65 years (78%). Average monthly waste was 2.7 lbs for pumps and 3.1 lbs for MDIs. Diabetes-related products contributed nearly 2% of household waste.
Conclusions: This study highlights the importance of improving recycling methods and reducing waste from diabetes devices.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2337/dc24-2522 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Quantifying Environmental Waste From Diabetes Devices in the U.S.
Diabetes Care
March 2025
Florida State University College of Nursing, Tallahassee, FL.
Objective: Diabetes devices, including continuous glucose monitors (CGMs) and insulin pumps, may significantly affect environmental sustainability and long-term resilience.
Research Design And Methods: This observational study enrolled 49 adults with diabetes using CGMs, insulin pumps, or multiple daily injections (MDIs; three or more per day). Participants completed daily surveys detailing the types and amounts of diabetes-related waste discarded.
Phenolic Preservatives Are Not the Sole Cause of Eosinophilic Infiltration at Infusion Pump Sites.
Diabetes Technol Ther
March 2025
Department of Physiology, Integrative Biosciences Center (IBio), Wayne State University, Detroit, MI, United States.
Skin reactions and discomfort associated with insulin infusion pumps limit user adherence. A recent histopathological study by Kalus et al. (DERMIS study) reported increased eosinophilic infiltration and imputed an inflammatory response to an allergen delivered at the catheter tip.
View Article and Find Full Text PDFPharmacotherapy of type 1 diabetes - part 3: Tomorrow.
Expert Opin Pharmacother
March 2025
The Association of Diabetes Investigators, Omaha, NE, USA.
Introduction: The last 100 years has seen type 1 diabetes, a previously fatal disease, transformed by the administration of exogenous insulin.
Areas Covered: a standard literature search using the Google and Microsoft search engines and PubMed was performed. The development of synthetic insulins with varying onsets and duration of action improved glucose control, essential to mitigate the microvascular and macrovascular consequences of diabetes.
A comprehensive study on the impact of L. fruit polysaccharide on myocardial fibrosis through animal experiments, network pharmacology and molecular docking.
Front Cardiovasc Med
February 2025
School of Pharmacy, Jining Medical University, Rizhao, China.
Background: Myocardial fibrosis (MF) is a prevalent pathological condition associated with various heart diseases, such as heart failure and arrhythmias, which disrupt electrical signals and reduce pumping efficiency. This research explored the therapeutic effects and potential mechanisms of L. fruit polysaccharide (LVFP) on MF.
View Article and Find Full Text PDFAn overview of insulin therapy for the non-specialist.
Diabetes Obes Metab
March 2025
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Nearly all health professionals, whatever their practice or speciality, now have contact with a significant number of insulin-using people with diabetes. People with type 1 diabetes are nearly universally managed on more complex insulin regimens, increasingly with complex support technology, and with some understanding of the concepts underlying these needed by anyone with responsibility for other aspects of their health care. People with type 2 diabetes usually come to insulin therapy in time, now with a prevalence for insulin administration of ≈50%, thanks to improved management of associated health risks giving longer life expectancy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!